{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:13:42Z","timestamp":1753877622868,"version":"3.41.2"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI135970","R01 AI140970","P30AI050410","3P30AI050410-26S1","T32 AI007001"],"award-info":[{"award-number":["R01 AI135970","R01 AI140970","P30AI050410","3P30AI050410-26S1","T32 AI007001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>HIV molecular cluster detection in the United States relies on HIV sequences obtained from drug resistance testing during clinical care (\u201croutine care sequences\u201d). This approach misses people who are not linked to care or who receive care but have uncollected or unreported sequences.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We collected \u201cHIV test sequences\u201d from remnant serum samples of people testing newly positive from 2018 through 2021 by a large public health laboratory in North Carolina. We incorporated the HIV test sequences into a statewide molecular cluster analysis and assessed impact on \u201cactive cluster\u201d detection (\u22655 members newly diagnosed). We described data gaps filled by HIV test sequences, comparing (1) the extent of care sequence missingness due to gaps in care linkage vs sequence collection or reporting and (2) the characteristics of people with an HIV test sequence who had a care sequence, care but no care sequence, or no evidence of care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 19 770 people included in the cluster analysis, 847 had an HIV test sequence, one-third of whom had no routine care sequence. We identified 13 additional active clusters (a 33% relative increase) and 40 larger active clusters after incorporating HIV test sequences. Most people with an HIV test sequence but no care sequence (78%) had another care indicator, suggesting sequence undercollection or underreporting, but a fifth (22%) had no evidence of care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Higher sequence coverage can improve cluster detection. While increased routine care sequence collection and reporting could fill many data gaps, sequencing remnant HIV test samples could include people without care linkage.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf305","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:51:01Z","timestamp":1747997461000},"source":"Crossref","is-referenced-by-count":0,"title":["Sequencing HIV Diagnostic Samples to Detect Genetic Clusters and Assess Sequence Coverage Gaps"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5627-8250","authenticated-orcid":false,"given":"Cara J","family":"Broshkevitch","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8353-386X","authenticated-orcid":false,"given":"Shuntai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalea","family":"Greifinger","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Enders","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Long","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Samoff","sequence":"additional","affiliation":[{"name":"Division of Public Health, North Carolina Department of Health and Human Services , Raleigh, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A","family":"Powers","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Mobley","sequence":"additional","affiliation":[{"name":"Division of Public Health, North Carolina Department of Health and Human Services , Raleigh, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon D W","family":"Frost","sequence":"additional","affiliation":[{"name":"Microsoft Premonition, Microsoft Strategic Missions and Technologies , Redmond, Washington ,","place":["USA"]},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-8937","authenticated-orcid":false,"given":"Erik","family":"Volz","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Imperial College London , London ,","place":["UK"]},{"name":"MRC Centre for Global Infectious Disease Analysis, Imperial College London , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Shone","sequence":"additional","affiliation":[{"name":"Division of Public Health, North Carolina Department of Health and Human Services , Raleigh, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4938-0644","authenticated-orcid":false,"given":"Joseph J","family":"Eron","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]},{"name":"Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron S","family":"Cohen","sequence":"additional","affiliation":[{"name":"Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Swanstrom","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]},{"name":"Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M","family":"Dennis","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2025062505203786200_ofaf305-B1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/v13040577","article-title":"Increasing capacity to detect clusters of rapid HIV transmission in varied populations\u2014United States","volume":"13","author":"Oster","year":"2021","journal-title":"Viruses"},{"key":"2025062505203786200_ofaf305-B2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.15585\/mmwr.mm7138a1","article-title":"Clusters of rapid HIV transmission among gay, bisexual, and other men who have sex with men\u2014United States, 2018\u20132021","volume":"71","author":"Perez","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"2025062505203786200_ofaf305-B3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.2018.21167","article-title":"HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable","volume":"321","author":"Eisinger","year":"2019","journal-title":"JAMA"},{"key":"2025062505203786200_ofaf305-B4","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"2025062505203786200_ofaf305-B5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"2025062505203786200_ofaf305-B6","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"2025062505203786200_ofaf305-B7","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.amepre.2021.05.029","article-title":"HIV cluster and outbreak detection and response: the science and experience","volume":"61","author":"Oster","year":"2021","journal-title":"Am J Prev Med"},{"key":"2025062505203786200_ofaf305-B8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/00333549241253092","article-title":"Enhancements to the national HIV surveillance system, United States, 2013\u20132023","volume":"139","author":"Satcher Johnson","year":"2024","journal-title":"Public Health Rep"},{"key":"2025062505203786200_ofaf305-B9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/QAI.0000000000000809","article-title":"Using molecular HIV surveillance data to understand transmission between subpopulations in the United States","volume":"70","author":"Oster","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025062505203786200_ofaf305-B10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/v12020142","article-title":"Characterization of molecular cluster detection and evaluation of cluster investigation criteria using machine learning methods and statewide surveillance data in Washington State","volume":"12","author":"Erly","year":"2020","journal-title":"Viruses"},{"key":"2025062505203786200_ofaf305-B11","doi-asserted-by":"crossref","first-page":"100968","DOI":"10.1016\/j.eclinm.2021.100968","article-title":"HIV-1 transmission linkages among persons with incident infection to inform public health surveillance","volume":"37","author":"Dennis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2025062505203786200_ofaf305-B12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/OLQ.0000000000000726","article-title":"Integration of contact tracing and phylogenetics in an investigation of acute HIV infection","volume":"45","author":"Dennis","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2025062505203786200_ofaf305-B13","doi-asserted-by":"crossref","first-page":"e0188922","DOI":"10.1128\/spectrum.01889-22","article-title":"Molecular epidemiology of HIV-1 subtype B infection across Florida reveals few large superclusters with metropolitan origin","volume":"10","author":"Rich","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2025062505203786200_ofaf305-B14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1089\/aid.2021.0031","article-title":"Characterization of HIV risk behaviors and clusters using HIV-transmission cluster engine among a cohort of persons living with HIV in Washington, DC","volume":"37","author":"Wilbourn","year":"2021","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025062505203786200_ofaf305-B15","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/infdis\/jiy431","article-title":"Growth of HIV-1 molecular transmission clusters in New York City","volume":"218","author":"Wertheim","year":"2018","journal-title":"J Infect Dis"},{"key":"2025062505203786200_ofaf305-B16","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.amepre.2021.05.039","article-title":"Response to a large HIV outbreak, Cabell County, West Virginia, 2018\u20132019","volume":"61","author":"McClung","year":"2021","journal-title":"Am J Prev Med"},{"key":"2025062505203786200_ofaf305-B17","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","article-title":"Responding to outbreaks of human immunodeficiency virus among persons who inject drugs\u2014United States, 2016\u20132019: perspectives on recent experience and lessons learned","volume":"222","author":"Lyss","year":"2020","journal-title":"J Infect Dis"},{"key":"2025062505203786200_ofaf305-B18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.15585\/mmwr.mm7210a3","article-title":"Public health response to clusters of rapid HIV transmission among Hispanic or Latino gay, bisexual, and other men who have sex with men\u2014metropolitan Atlanta, Georgia, 2021\u20132022","volume":"72","author":"Saldana","year":"2023","journal-title":"Morb Mortal Wkly Rep"},{"key":"2025062505203786200_ofaf305-B19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAI.0000000000001856","article-title":"Identifying clusters of recent and rapid HIV transmission through analysis of molecular surveillance data","volume":"79","author":"Oster","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025062505203786200_ofaf305-B20","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/molbev\/msy016","article-title":"HIV-TRACE (Transmission Cluster Engine): a tool for large scale molecular epidemiology of HIV-1 and other rapidly evolving pathogens","volume":"35","author":"Kosakovsky Pond","year":"2018","journal-title":"Mol Biol Evol"},{"author":"Panel of Antiretroviral Guidelines for Adults and Adolescents","key":"2025062505203786200_ofaf305-B21"},{"key":"2025062505203786200_ofaf305-B22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/QAD.0000000000003192","article-title":"Baseline HIV drug-resistance testing: 12 US jurisdictions, 2014\u20132019","volume":"36","author":"Hugueley","year":"2022","journal-title":"AIDS"},{"key":"2025062505203786200_ofaf305-B23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/aid.2018.0181","article-title":"Estimating effects of HIV sequencing data completeness on transmission network patterns and detection of growing HIV transmission clusters","volume":"35","author":"Dasgupta","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025062505203786200_ofaf305-B24","doi-asserted-by":"crossref","first-page":"19230","DOI":"10.1038\/s41598-022-21924-8","article-title":"Impact of molecular sequence data completeness on HIV cluster detection and a network science approach to enhance detection","volume":"12","author":"Mazrouee","year":"2022","journal-title":"Sci Rep"},{"key":"2025062505203786200_ofaf305-B25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/QAI.0000000000001905","article-title":"Prediction of HIV transmission cluster growth with statewide surveillance data","volume":"80","author":"Billock","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025062505203786200_ofaf305-B26","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/jiaa417","article-title":"Near real-time identification of recent human immunodeficiency virus transmissions, transmitted drug resistance mutations, and transmission networks by multiplexed primer ID\u2013next-generation sequencing in North Carolina","volume":"223","author":"Zhou","year":"2021","journal-title":"J Infect Dis"},{"key":"2025062505203786200_ofaf305-B27","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/infdis\/jiad211","article-title":"Use of next-generation sequencing in a state-wide strategy of HIV-1 surveillance: impact of the SARS-COV-2 pandemic on HIV-1 diagnosis and transmission","volume":"228","author":"Zhou","year":"2023","journal-title":"J Infect Dis"},{"author":"North Carolina HIV\/STD\/Hepatitis Surveillance Unit","key":"2025062505203786200_ofaf305-B28"},{"key":"2025062505203786200_ofaf305-B29","first-page":"512","article-title":"Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees","volume":"10","author":"Tamura","year":"1993","journal-title":"Mol Biol Evol"},{"author":"North Carolina HIV\/STD\/Hepatitis Surveillance Unit","key":"2025062505203786200_ofaf305-B30"},{"author":"Centers for Disease Control and Prevention, National Center for Health Statistics","key":"2025062505203786200_ofaf305-B31"},{"key":"2025062505203786200_ofaf305-B32","doi-asserted-by":"crossref","first-page":"e1002552","DOI":"10.1371\/journal.pcbi.1002552","article-title":"Simple epidemiological dynamics explain phylogenetic clustering of HIV from patients with recent infection","volume":"8","author":"Volz","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"2025062505203786200_ofaf305-B33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/09540121.2018.1545983","article-title":"Completeness of HIV nucleotide sequence ascertainment and its potential impact on understanding HIV transmission\u2014Maryland, 2011\u20132013","volume":"31","author":"Brooks","year":"2019","journal-title":"AIDS Care"},{"key":"2025062505203786200_ofaf305-B34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/09540121.2017.1316356","article-title":"Receipt and timing of HIV drug resistance testing in six US jurisdictions","volume":"29","author":"Dasgupta","year":"2017","journal-title":"AIDS Care"},{"key":"2025062505203786200_ofaf305-B35","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/cid\/ciad699","article-title":"Pre-exposure prophylaxis use history in people with antiretroviral resistance at HIV diagnosis: findings from New York City HIV surveillance and partner services, 2015\u20132022","volume":"78","author":"Misra","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025062505203786200_ofaf305-B36","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/cid\/ciz372","article-title":"Clinical impact and cost-effectiveness of genotype testing at human immunodeficiency virus diagnosis in the United States","volume":"70","author":"Hyle","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025062505203786200_ofaf305-B37","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0000000000002210","article-title":"In defense of baseline genotypic antiretroviral resistance testing","volume":"83","author":"Lang","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025062505203786200_ofaf305-B38","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1016\/S2352-3018(23)00228-X","article-title":"HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis","volume":"10","author":"Loosli","year":"2023","journal-title":"Lancet HIV"},{"key":"2025062505203786200_ofaf305-B39","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1016\/S2214-109X(24)00553-9","article-title":"Predicted dolutegravir resistance in people living with HIV in South Africa during 2020\u201335: a modelling study","volume":"13","author":"Loosli","year":"2025","journal-title":"Lancet Glob Health"},{"key":"2025062505203786200_ofaf305-B40","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1097\/QAD.0000000000003228","article-title":"Baseline HIV genotype drug resistance testing: is it time for more or less?","volume":"36","author":"Wood","year":"2022","journal-title":"AIDS"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf305\/63307899\/ofaf305.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/6\/ofaf305\/63307899\/ofaf305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/6\/ofaf305\/63307899\/ofaf305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:20:47Z","timestamp":1750843247000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf305\/8142297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf305","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,5,23]]},"article-number":"ofaf305"}}